Thomas R. Kuhn - Dec 26, 2024 Form 4/A - Amendment Insider Report for Anterix Inc. (ATEX)

Role
Director, Chairman
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Dec 26, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/14/2025, 04:16 PM
Date Of Original Report
Dec 30, 2024
Previous filing
Dec 17, 2024
Next filing
Jan 24, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +7.11K $0.00 7.11K Dec 26, 2024 Common Stock 7.11K $31.25 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the previously reported grant amount of 61,804 option shares to the Reporting Person to reflect an actual grant of 7,108 option shares. The previously reported amount exceeded the compensation limit for non-employee directors set forth in the Issuer's 2023 Stock Plan by 54,696 option shares (the "Excess Option Shares"). The grant of the Excess Option Shares was null and void and has been rescinded by the Issuer.
F2 The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date.